IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible

Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible

Discussing Safety, Tolerability of Tenapanor in Pediatric IBS-C patients, with Thomas Wallach, MD Thomas Wallach, MD

Thomas Wallach, MD, discusses phase 3 safety data of tenapanor in pediatric patients with IBS-C, presented at the 2025 NASPGHAN Annual Meeting.

Predicting Teduglutide Treatment Response for Pediatric SBS-IF, With Valeria Cohran, MD

Predicting Teduglutide Treatment Response for Pediatric SBS-IF, With Valeria Cohran, MD

Microbiota Restoration Therapy: A New Era in C. difficile Management, With Paul Feuerstadt, MD Paul Feuerstadt, MD

FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.

H. pylori Geographical Prevalence and NASPGHAN/ESPGHAN Guidelines, With Silvana Bonilla, MD Silvana Bonilla, MD

Multicenter data presented by Silvana Bonilla, MD, at NASPGHAN 2025 highlight regional variation in pediatric H. pylori prevalence and support selective biopsy practices guided by clinical suspicion.

5 Gastroenterology Headlines You Missed in November 2025

5 Gastroenterology Headlines You Missed in November 2025

Todays Updates

This Week on NeurologyLive® — December 22, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis Marco Meglio

Continuem's PIPE-307 trial for relapsing-remitting multiple sclerosis failed to meet primary goals, yet the company remains committed to exploring future therapies.

Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease Marco Meglio

Gain Therapeutics advances Parkinson's treatment with GT 2287, showcasing promising safety and tolerability in ongoing trials. Discover the latest findings.

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

COPD in 2025: Year in Review

COPD in 2025: Year in Review

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

Nephrology in 2025: Year in Review

Nephrology in 2025: Year in Review

Todays Updates

This Week on NeurologyLive® — December 22, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis Marco Meglio

Continuem's PIPE-307 trial for relapsing-remitting multiple sclerosis failed to meet primary goals, yet the company remains committed to exploring future therapies.

Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease Marco Meglio

Gain Therapeutics advances Parkinson's treatment with GT 2287, showcasing promising safety and tolerability in ongoing trials. Discover the latest findings.

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia

COPD in 2025: Year in Review

COPD in 2025: Year in Review

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector

Nephrology in 2025: Year in Review

Nephrology in 2025: Year in Review

Latest News

Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible

Thomas Wallach, MD, discusses phase 3 safety data of tenapanor in pediatric patients with IBS-C, presented at the 2025 NASPGHAN Annual Meeting.

Predicting Teduglutide Treatment Response for Pediatric SBS-IF, With Valeria Cohran, MD

FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.

Multicenter data presented by Silvana Bonilla, MD, at NASPGHAN 2025 highlight regional variation in pediatric H. pylori prevalence and support selective biopsy practices guided by clinical suspicion.

5 Gastroenterology Headlines You Missed in November 2025

News All Time

Conference Preview: American College of Gastroenterology’s 2025 Annual Scientific Meeting Abigail Brooks, MA

View slated expert interviews and 6 clinical GI, hepatology, and endoscopy trials to watch at ACG 2025.

ACP Releases Position Paper on Colorectal Cancer Screening, Surveillance Abigail Brooks, MA

The ACP Performance Measurement Committee reviewed 5 performance measures for CRC screening, ultimately only supporting 1 of them.

GERD Linked To Heightened Risk of New Alcohol Use Disorder Diagnosis Abigail Brooks, MA

Findings suggest having GERD incurs an 18% greater risk of a new AUD diagnosis, presenting an opportunity to discuss alcohol use with patients.

Demographic Disparities in GLP-1 RA Trial Enrollment Raise Inclusivity, Validity Concerns Abigail Brooks, MA

Despite bearing a greater obesity burden, Black, Hispanic, and American Indian/Native individuals are underrepresented in GLP-1 RA RCTs for weight loss.

Emphasizing Bone Health Screening in GI, With Alexandria Markley, MD Alexandria Markley, MD

Markley describes the importance of monitoring bone health in patients with IBD and celiac disease and explains her research showing low screening rates.

Holding Versus Continuing GLP-1s, GIPs Before Endoscopy, With Akram Ahmad, MD Akram Ahmad, MD

Ahmad reviews findings from the OCULUS trial highlighting the benefits of holding a single dose of GLP-1 and GIP-1 agonists prior to upper endoscopy.

Solidifying Dupilumab’s Role in Eosinophilic Esophagitis Care, With Evan Dellon, MD, MPH Evan Dellon, MD, MPH

Dellon reviews data from a post-hoc analysis of dysphagia and odynophagia in LIBERTY EoE TREET and a pooled analysis of endoscopic improvement in 2 trials.

FDA Approves Single-Dose Formulation of Mirikizumab-mrkz for Ulcerative Colitis Ryan Livingston

FDA approves Omvoh (mirikizumab-mrkz) for monthly maintenance of ulcerative colitis, simplifying treatment for patients with this chronic condition.

GLP-1 RAs Reduce Anemia Risk in Patients with Celiac Disease Abigail Brooks, MA

GLP-1 RA use was linked to a significant survival benefit and reduced risk of iron deficiency anemia in patients with celiac disease.

Closing the Diagnostic Gap in Eosinophilic Esophagitis, With Walker Redd, MD Walker Redd, MD

Redd reviews real-world data highlighting low rates of biopsies performed among patients with esophageal food impaction-related emergency department visits.

1 in 10 People Without Celiac Disease Report Gluten or Wheat Sensitivity Chelsie Derman

Study finds non-celiac gluten or wheat sensitivity is more common in women and linked to IBS, anxiety, and depression.

Don't let food poisoning crash your Thanksgiving dinner

Thanksgiving is a time for family, friends and feasting. However, amid the joy of gathering and indulging in delicious food, it is essential to keep food safety in mind. Foodborne illnesses can quickly put a damper on your ...

New drug offers hope to bladder cancer patients

Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.

Medications change our gut microbiome in predictable ways, research reveals

Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve ...

How the gut builds long-lasting immunity after viral infections

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.

Researchers find simple way to make kale healthier by pairing it with oil-based dressings

Think that kale salad you're eating is a superfood? Without the right ingredient it might not be living up to its hype. But don't worry.

Recommended News For You

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

CAR-T Warning for Secondary Malignancies: Warranted or Not?

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Recommended Articles For You

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD) 

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

2.

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

3.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

4.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

5.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

1.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

2.

Everything You Need to Know About CA 19-9 and Cancer Diagnosis

3.

Survival Rate Dynamics in Hematologic and Solid Malignancies

4.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

5.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XIV

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

3.

Navigating the Complexities of Ph Negative ALL - Part XIII

4.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot